SCHEMBL29426482

SCHEMBL29426482

COC(=O)Cn1nc(CCF)c2ccc(Br)cc2c1=O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.45
CASP3 P42574 2/20 0.43
NLRP3 Q96P20 1/20 0.42
AKR1B1 P15121 4/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALOX15 P16050 1/20 0.38
CDK1 P06493 1/20 0.37
EGFR P00533 1/20 0.37
MCL1 Q07820 1/20 0.36
FPR1 P21462 1/20 0.36
FPR2 P25090 1/20 0.36
S1PR2 O95136 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26733005 1.00 TSHR (0.45) TSHRCASP3NLRP3AKR1B1CYP1A2
SCHEMBL26733003 0.95 TSHR (0.47) TSHRCASP3NLRP3AKR1B1CYP1A2
SCHEMBL29426501 0.92 TSHR (0.47) TSHRCASP3NLRP3AKR1B1CYP1A2
SCHEMBL26733142 0.92 TSHR (0.47) TSHRCASP3NLRP3AKR1B1CYP1A2
SCHEMBL29426497 0.92 TSHR (0.47) TSHRCASP3NLRP3AKR1B1CYP1A2
SCHEMBL26733016 0.90 TSHR (0.46) TSHRCASP3NLRP3AKR1B1CYP1A2
SCHEMBL29426529 0.90 TSHR (0.46) TSHRCASP3NLRP3AKR1B1CYP1A2
SCHEMBL26733144 0.88 TSHR (0.48) TSHRCASP3NLRP3AKR1B1CYP1A2
SCHEMBL29426511 0.88 TSHR (0.48) TSHRCASP3NLRP3AKR1B1CYP1A2
SCHEMBL26733141 0.87 TSHR (0.50) TSHRCASP3NLRP3AKR1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4196125-A1 COMPOUNDS, COMPOSITIONS AND METHODS Denali Therapeutics Inc. (US) 2023-06-21 EP disclosed
WO-2022036204-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2022-02-17 WO disclosed